Twice-Daily Aspirin Regimen May Confer Cardiovascular Benefit In Patients With T2D, Study Indicates.

“Patients with type 2 diabetes [T2D] but without existing cardiovascular disease experienced a time-dependent increase in platelet aggregation in the 24 hours after once-daily aspirin therapy,” researchers reported after analyzing “data from 21 patients with type 2 diabetes and 21 age- and sex-matched controls who received once-daily aspirin for 6 days.” The findings, which were presented at the European Association for the Study of Diabetes Annual Meeting, indicate that “a twice-daily aspirin regimen could provide CV benefit.” https://www.healio.com/endocrinology/diabetes/news/online/%7B83fdb2c6-4d77-40ae-a0fb-9e2961baea45%7D/twice-daily-aspirin-may-confer-cv-benefit-in-type-2-diabetes